STAR ARRAY PTE LTD – Trademark Portfolio
Entity Type: 03
STAR ARRAY PTE LTD holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 2 are pending. Notable registered marks include XDIVE, PEAK V, ONSITEGENE, and STAR ARRAY. The owner is based in SINGAPORE.
2 TUKANG INNOVATION GROVE, #09-09,
JTC MEDTECH HUB
SINGAPORE 618305 , SG
Showing of trademarks Trademarks
Trademark Classifications
STAR ARRAY PTE LTD's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does STAR ARRAY PTE LTD have?
STAR ARRAY PTE LTD has 11 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending, 3 abandoned, 1 cancelled.
What trademark classes does STAR ARRAY PTE LTD file in?
STAR ARRAY PTE LTD files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are STAR ARRAY PTE LTD's most well-known trademarks?
STAR ARRAY PTE LTD's registered trademark portfolio includes well-known marks such as XDIVE, PEAK V, ONSITEGENE, and STAR ARRAY. These are among 5 currently registered trademarks in the portfolio.
What is STAR ARRAY PTE LTD's trademark registration success rate?
STAR ARRAY PTE LTD has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 2 applications are pending review.